These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

948 related items for PubMed ID: 18701528

  • 21. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
    Vikram HR, Havill NL, Koeth LM, Boyce JM.
    J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
    [Abstract] [Full Text] [Related]

  • 22. Daptomycin for methicillin-resistant Staphylococcus aureus infections of the spine.
    Burdette SD.
    Spine J; 2009 Jun; 9(6):e5-8. PubMed ID: 19112049
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection.
    Rouse MS, Steckelberg JM, Patel R.
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):363-5. PubMed ID: 17449212
    [Abstract] [Full Text] [Related]

  • 24. Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.
    Boucher HW, Sakoulas G.
    Clin Infect Dis; 2007 Sep 01; 45(5):601-8. PubMed ID: 17682996
    [Abstract] [Full Text] [Related]

  • 25. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?
    Gould IM, Cauda R, Esposito S, Gudiol F, Mazzei T, Garau J.
    Int J Antimicrob Agents; 2011 Mar 01; 37(3):202-9. PubMed ID: 21300528
    [Abstract] [Full Text] [Related]

  • 26. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW, Murray CK, Holmes RL, Patterson JE, Jorgensen JH.
    Diagn Microbiol Infect Dis; 2008 Apr 01; 60(4):437-40. PubMed ID: 18096352
    [Abstract] [Full Text] [Related]

  • 27. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK, Wennersten C, Venkataraman L, Eliopoulos GM, Moellering RC, Karchmer AW.
    Clin Infect Dis; 2009 Oct 15; 49(8):1169-74. PubMed ID: 19769538
    [Abstract] [Full Text] [Related]

  • 28. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J.
    Clin Infect Dis; 2008 Jan 15; 46(2):193-200. PubMed ID: 18171250
    [Abstract] [Full Text] [Related]

  • 29. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Kullar R, Davis SL, Kaye KS, Levine DP, Pogue JM, Rybak MJ.
    Pharmacotherapy; 2013 Jan 15; 33(1):3-10. PubMed ID: 23307539
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of mitral MRSA endocarditis using daptomycin].
    Senneville E, Beltrand E, Legout L, Leroy O, Fayad G.
    Med Mal Infect; 2008 Dec 15; 38 Spec No 2():13-5. PubMed ID: 19185204
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Use of daptomycin in a pregnant patient with Staphylococcus aureus endocarditis.
    Stroup JS, Wagner J, Badzinski T.
    Ann Pharmacother; 2010 Apr 15; 44(4):746-9. PubMed ID: 20197474
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Therapy for methicillin-resistant Staphylococcus aureus.
    Torres-Tortosa M, Caballero-Granado FJ, Canueto J.
    N Engl J Med; 2006 Nov 16; 355(20):2153-4; author reply 2155. PubMed ID: 17120350
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
    Yin LY, Calhoun JH, Thomas TS, Wirtz ED.
    J Antimicrob Chemother; 2009 Feb 16; 63(2):357-60. PubMed ID: 19060292
    [Abstract] [Full Text] [Related]

  • 38. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC.
    Int J Antimicrob Agents; 2007 Nov 16; 30(5):398-408. PubMed ID: 17888634
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.
    Clin Infect Dis; 2009 Mar 15; 48(6):713-21. PubMed ID: 19207079
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.